clofibrate has been researched along with dipyridamole in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 61 (89.71) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (1.47) | 29.6817 |
2010's | 6 (8.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Haft, JI | 1 |
Dechavanne, M; Lagarde, M | 1 |
Genton, E; Rainwater, J; Steele, P; Vogel, R | 1 |
Mustard, JF; Packham, MA | 1 |
Verstraete, M | 6 |
Bokarev, IN; Komarov, FI; Liusov, VA | 1 |
Hirsh, J; Turpie, AG | 1 |
Zicot, M | 1 |
Yasunaga, K | 1 |
Gryglik, J | 1 |
Salvadori, G; Zannino, L | 1 |
Caen, JP; Wautier, JL | 1 |
Hirsh, J | 2 |
Dettori, AG; Pini, M; Quintavalla, R | 1 |
Latour, JG | 1 |
Gantmacher, ML | 1 |
Barillari, C; Bianchi, V; Parenti, M; Pasquali, R; Vezzadini, P | 1 |
Mehta, J; Mehta, P | 1 |
Hladovec, J | 1 |
Dechavanne, M; Follea, G; Trzeciak, MC | 1 |
Weiss, HJ | 2 |
Gent, M; Genton, E; Harker, LA; Hirsh, J | 4 |
Gallus, AS; Hirsh, J | 1 |
Aledort, LM | 1 |
Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
Gent, M; Genton, E; Hirsh, J | 1 |
Ellis, J; Genton, E; Steele, P | 1 |
Vermylen, J | 1 |
Borhani, NO | 1 |
Arribas Castrillo, JM; Durán García, S; Quintero de Juana, A; Romero, E; Zurro Hernández, J | 1 |
Buchvarova, B; Doĭchinov, A | 1 |
Bouvier, CA | 1 |
Hammerl, H; Nebosis, G; Pichler, O; Studlar, M | 1 |
Alessandri, M; Coccheri, S; De Rosa, V | 1 |
Marshall, AJ | 1 |
Avellone, G; Davì, G; Mandalà, V; Novo, S; Pinto, A; Raneli, G; Riolo, FP | 1 |
Bousser, MG | 2 |
Stamler, J | 1 |
Bertha, G; Lechner, H; Ott, E | 1 |
Ramirez-Lassepas, M | 1 |
Gorelova, NR; Nikulina, GG; Petrun, NM; Pyrig, LA | 1 |
Birgens, HS; Hansen, MS | 1 |
Loogen, F; Misera, R; Reimers, HJ; Schneider, W | 1 |
Cristol, R | 1 |
Olivella, J; Vicens, B | 1 |
Turpie, AG | 1 |
Mel'man, NIa; Nikulina, GG; Petrun', NM; Pyrig, LA; Romaniuk, GV | 1 |
Ahmad, S | 1 |
Paredero Del Bosque Martin, V | 1 |
Croveri, G | 1 |
33 review(s) available for clofibrate and dipyridamole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1978 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agents; Humans; Pentoxifylline; Snake Venoms; Xanthinol Niacinate | 1979 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
[Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease].
Topics: Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation | 1979 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type 1; Dipyridamole; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Hyperlipidemias; Platelet Aggregation; Polycythemia Vera; Prostaglandins E | 1979 |
Pharmacology of platelet-suppressive agents.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cell Membrane; Clofibrate; Dipyridamole; Epoprostenol; Halofenate; Heparin; Humans; Imidazoles; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins E; Prostaglandins, Synthetic | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombosis | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemia; Kidney Diseases; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Serotonin Antagonists; Sulfinpyrazone; Sympathomimetics; Thrombosis | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibrinolytic Agents; Humans; Hydroxychloroquine; Myocardial Infarction; Plasminogen Activators; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Dogs; Heparin; Humans; Male; Platelet Aggregation; Thromboembolism; Thrombophlebitis; Thrombosis | 1976 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Graft Rejection; Heart Valve Prosthesis; Hemostasis; Humans; Kidney Transplantation; Myocardial Infarction; Platelet Aggregation; Serotonin Antagonists; Thromboembolism; Thrombosis; Transplantation, Homologous | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Topics: Adult; Aspirin; Blood Platelets; Child; Clofibrate; Dextrans; Dipyridamole; Drug Combinations; Graft Rejection; Heart Valve Prosthesis; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Diuretics; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Sulfinpyrazone | 1981 |
[Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
Topics: Adult; Anticoagulants; Antithrombin III; Arrhythmias, Cardiac; Clofibrate; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation; Pyridines; Sulfinpyrazone; Suloctidil; Thiophenes; Ticlopidine | 1981 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggregation; Erythrocytes; Humans; Ischemic Attack, Transient; Pentoxifylline; Plasma; Platelet Aggregation; Sulfinpyrazone | 1983 |
Platelet inhibitors for TIAs. A review of prospective drug trial results.
Topics: Aged; Aspirin; Clofibrate; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation; Prospective Studies; Recurrence; Sulfinpyrazone | 1984 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Humans; Kidney Diseases; Sulfinpyrazone; Thrombosis | 1980 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Heart Valve Diseases; Humans; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1981 |
15 trial(s) available for clofibrate and dipyridamole
Article | Year |
---|---|
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Hemostasis; Humans; Pentoxifylline; Phenothiazines; Piperazines; Pyridinolcarbamate | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Survival; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Sulfinpyrazone; Thrombocytosis; Thromboembolism | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Hydroxychloroquine; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Topics: Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
[Platelets and coronary artery disease (CAD) (author's transl)].
Topics: Animals; Aspirin; Autopsy; Blood Platelets; Cardiomyopathies; Cell Wall; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Heparin Antagonists; Humans; Platelet Aggregation; Risk; Sulfinpyrazone | 1980 |
Plafibride: clinical trial of a new platelet antiaggregating agent.
Topics: Adenosine Diphosphate; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Dipyridamole; Double-Blind Method; Humans; Middle Aged; Platelet Aggregation; Time Factors | 1981 |
28 other study(ies) available for clofibrate and dipyridamole
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
Topics: Blood Platelets; Clofibrate; Collagen; Dipyridamole; Heparin; Humans; Peroxides; Prospective Studies; Prostaglandins; Prostaglandins F; Pyridines; Sulfinpyrazone; Thiophenes; Thrombophlebitis; Thrombosis | 1977 |
Platelet-suppressant therapy in patients with coronary artery disease.
Topics: Adult; Blood Platelets; Cell Survival; Clofibrate; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Male; Middle Aged; Saphenous Vein; Sulfinpyrazone; Transplantation, Autologous | 1978 |
[The clofibrate-dipyridamole combination in the treatment of athero-arteriosclerotic vasculopathy].
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Drug Evaluation; Female; Fibrinogen; Glucose Tolerance Test; Humans; Lipids; Male; Middle Aged; Platelet Aggregation; Prothrombin | 1979 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biological; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1979 |
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Topics: Animals; Aspirin; Citrates; Clofibrate; Dipyridamole; Endothelium; Female; Hydroxychloroquine; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Myocardial Infarction; Nicergoline; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofibrate; Dextrans; Dipyridamole; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1978 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1977 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1976 |
Proceedings: Comparative effects of platelet suppressant drugs on platelet survival time.
Topics: Blood Platelets; Cell Survival; Clofibrate; Dipyridamole; Humans; In Vitro Techniques; Sulfinpyrazone; Thromboembolism | 1975 |
Clinical pharmacology of anti-aggregating substances.
Topics: Aspirin; Clofibrate; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1975 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
[Prophylaxis of thrombogenesis in the diabetic patient].
Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation; Thrombosis | 1974 |
[Long-term medicinal prevention in patients who have suffered myocardial infarction].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Clofibrate; Dipyridamole; Drug Therapy, Combination; Exercise Therapy; Female; Hemorrhage; Humans; Hypnotics and Sedatives; Iron; Male; Middle Aged; Myocardial Infarction; Recurrence; Time Factors | 1974 |
[Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
Topics: Adult; Cholesterol; Clofibrate; Dipyridamole; Drug Synergism; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides | 1973 |
Platelets and contact activation of blood clotting. Influence of some aggregation inhibitors.
Topics: Adenosine Diphosphate; Blood Coagulation; Blood Platelets; Butyrates; Clofibrate; Dipyridamole; Fibrinolysis; Heparin; Molecular Weight; Phosphatidylcholines; Platelet Adhesiveness; Polysaccharides | 1971 |
Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis.
Topics: Adolescent; Adult; Arteriosclerosis; Clofibrate; Dipyridamole; Female; Glomerulonephritis; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Niacin | 1984 |
[Correction of lipid metabolism disorders in glomerulonephritis].
Topics: Adult; Clofibrate; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Lipid Metabolism; Male; Middle Aged; Nicotinic Acids | 1981 |
Drug interactions with oral anticoagulants.
Topics: Anticoagulants; Benzothiadiazines; Cimetidine; Clofibrate; Dipyridamole; Diuretics; Drug Interactions; Humans; Metronidazole; Sodium Chloride Symporter Inhibitors; Sulfinpyrazone | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |